Skip to content

EPRX

Eupraxia Pharmaceuticals, Inc.

NASDAQ · Healthcare · Biotechnology · CA

$6.76
−1.74%
Ask drillr

Forward multiples

Based on analyst estimates

P/E forward
—
P/E 2026E
—
P/E 2027E
—
P/E 2028E
—
P/S forward
—

Trailing multiples

Trailing twelve months

P/E TTM
—
PEG TTM
—
Price / book
3.41x
Price / sales
—
Price / cash flow
-12.45x

Enterprise value

Enterprise value
$343.0M
EV / sales
—
EV / EBITDA
-6.88x
EV / EBIT
-6.01x
Market cap
$446.7M

Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026